C

Chartwave

Description

Chartwave

Investor Profile

Chartwave has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series F rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biopharma, Biotechnology, Therapeutics.

Stage Focus

  • Series F (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Chartwave frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 1
Sigma Group
North America, New Jersey, United States, Saddle River
Co-Investments: 1
dievini Hopp Biotech Holding
Europe, Baden-Wurttemberg, Germany, Walldorf
Co-Investments: 1
Co-Investments: 1
Northview LifeSciences
North America, British Columbia, Canada, Vancouver
Co-Investments: 1

What are some of recent deals done by Chartwave?

CureVac

Tübingen, Baden-Wurttemberg, Germany

CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.

BiopharmaBiotechnologyTherapeutics
Series FNov 3, 2015
Amount Raised: $107,974,788